1
|
Corcoran M, Mereckiene J, Cotter S, Murchan S, Lo SW, McGee L, Breiman RF, Cunney R, Humphreys H, Bentley SD, Gladstone RA. Using genomics to examine the persistence of Streptococcus pneumoniae serotype 19A in Ireland and the emergence of a sub-clade associated with vaccine failures. Vaccine 2021; 39:5064-5073. [PMID: 34301430 DOI: 10.1016/j.vaccine.2021.06.017] [Citation(s) in RCA: 9] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/12/2021] [Revised: 06/04/2021] [Accepted: 06/07/2021] [Indexed: 11/20/2022]
Abstract
BACKGROUND Streptococcus pneumoniae serotype 19A remains a significant cause of invasive pneumococcal disease (IPD) in Ireland despite the successful introduction of a 13-valent pneumococcal conjugate vaccine (PCV13) in 2010 which reduced the overall incidence of IPD in children. METHODS Invasive Streptococcus pneumoniae serotype 19A isolates from the Irish reference laboratory between 2007-08 and 2017-18 were analysed using whole genome sequencing (WGS) to investigate the persistence of this vaccine-preventable serotype. We compared the entire national 19A collection to other international collections using a standardised nomenclature of Global Pneumococcal Sequencing Clusters (GPSC). RESULTS Expansion of GPSCs and clonal complexes (CCs) may have been associated with vaccine introduction and antimicrobial prescribing policies. A sub-clade of GPSC1-CC320 (n = 25) unique to Ireland, included five of the ten vaccine failures/breakthrough cases identified (p = 0.0086). This sub-clade was not observed in a global GPSC1-CC320 collection. All isolates within the sub-clade (n = 25) contained a galE gene variant rarely observed in a global pneumococcal collection (n = 37/13454, p < 0.001) nor within GPSC1-CC320 (n = 19/227) (p < 0.001). The sub-clade was estimated to have emerged at the start of the PCV-vaccine era (ancestral origin 2000, range 1995-2004) and expanded in Ireland, with most isolated after PCV13 introduction (n = 24/25). CONCLUSIONS The identification of a sub-clade/variant of serotype 19A highlights the benefit of using WGS to analyse genotypes associated with persistence of a preventable serotype of S. pneumoniae. Particularly as this sub-clade identified was more likely to be associated with IPD in vaccinated children than other 19A genotypes. It is possible that changes to the galE gene, which is involved in capsule production but outside of the capsular polysaccharide biosynthesis locus, may affect bacterial persistence within the population. Discrete changes associated with vaccine-serotype persistence should be further investigated and may inform vaccine strategies.
Collapse
Affiliation(s)
- M Corcoran
- Irish Meningitis and Sepsis Reference Laboratory, Children's Health Ireland at Temple Street, Dublin, Ireland; Department of Clinical Microbiology, Royal College of Sugeons in Ireland, Dublin, Ireland.
| | - J Mereckiene
- Health Protection Surveillance Centre, Dublin, Ireland
| | - S Cotter
- Health Protection Surveillance Centre, Dublin, Ireland
| | - S Murchan
- Health Protection Surveillance Centre, Dublin, Ireland
| | - S W Lo
- Parasites and Microbes, Wellcome Sanger Institute, Hinxton, UK
| | - L McGee
- Centers for Disease Control and Prevention, Atlanta, GA, USA
| | - R F Breiman
- Department of Global Health, Rollins School Public Health, Emory University, Atlanta, GA, USA
| | - R Cunney
- Irish Meningitis and Sepsis Reference Laboratory, Children's Health Ireland at Temple Street, Dublin, Ireland; Department of Clinical Microbiology, Royal College of Sugeons in Ireland, Dublin, Ireland; Department of Microbiology, Children's Health Ireland at Temple Street, Dublin, Ireland
| | - H Humphreys
- Department of Clinical Microbiology, Royal College of Sugeons in Ireland, Dublin, Ireland; Department of Microbiology, Beaumont Hospital, Dublin, Ireland
| | - S D Bentley
- Parasites and Microbes, Wellcome Sanger Institute, Hinxton, UK
| | - R A Gladstone
- Parasites and Microbes, Wellcome Sanger Institute, Hinxton, UK; Department of Biostatistics, Institute of Basic Medical Sciences, University of Oslo, N-0317 Oslo, Norway
| |
Collapse
|
2
|
Randles M, Hayes M, Cotter S, Saramago I, McGrath K, O'Caoimh R, O'Connor K, O'Hea A, Hannon E. 147 Assessing Assessment: An Audit of Continence Assessment and Documentation in a City Centre Teaching Hospital. Age Ageing 2019. [DOI: 10.1093/ageing/afz103.88] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Abstract
Background
Urinary incontinence (UI) is defined by the International Continence Society as “any involuntary leakage of urine.” UI can negatively impact patients' physical and mental wellbeing and quality of life. Since older adults constitute a growing hospital population, evaluation and improvement of this patient group's quality of care is recognized as a priority in the study hospital. A continence assessment helps to determine what the problem is and what management is required.
This audit aims to determine whether appropriate assessments of continence in older adults presenting to the hospital setting were completed and documented.
Methods
An audit tool was adapted from the Royal College of Physicians National Continence Audit tool and the hospital's own elimination documentation pathway. On a chosen day a general medical ward and a specialist geriatric medicine ward were assessed. Medical charts, nursing notes, emergency department proforma, frailty intervention team proforma and skin integrity proforma were reviewed. Documentation of continence status, symptoms, type, investigations, continence wear, catheterisation and management were assessed. Continence care plans and evidence of communication/discussion with patients were also assessed.
Results
Thirty-one sets of documentation were reviewed. Twenty-four patients were aged over 65. Of these patients 12 were male and 12 were female. Four patients had no continence status documented. Forty-two percent of those reviewed over 65 had documented incontinence and of these only 40% had the elimination section of their nursing proforma fully completed. Six of the patients with documented incontinence had their symptoms/type of incontinence documented. Two Patients had urinary catheters, the indications for these catheters were documented
Conclusion
This audit found that overall the assessment and documentation of continence in older adults was sub-optimal. Based on this audit an assessment tool and education program will be introduced to the specialist geriatric medicine ward with the goal of improving assessment of continence and optimal management.
Collapse
Affiliation(s)
| | - Mary Hayes
- Mercy University Hospital, Cork, Ireland
| | | | | | | | | | | | - Anne O'Hea
- Mercy University Hospital, Cork, Ireland
| | | |
Collapse
|
3
|
Randles M, Hickey S, Cotter S, Walsh C, O'Connor K, O'Sullivan C, McGrath K, O'Sullivan A, Looney E, Maher S, McGuaran J, Higgins A, Quirke A, Allen Y. 144 The Use of a Multidisciplinary Team Discharge “Huddle” to Improve Patient Flow and Planning. Age Ageing 2019. [DOI: 10.1093/ageing/afz102.30] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Background
Patient flow, the movement of patients is an integral part of the patient care pathway. With the goal of improving overall patient care and discharge planning, a hospital wide, multidisciplinary team based, patient discharge meeting or ‘HUDDLE’ was devised with the goal of facilitating onward care planning for all inpatients especially those with complex discharge needs in a city centre teaching hospital.
Methods
The patient flow huddle has evolved to include a Patient Flow Clinical Nurse Manager, Bed Manager, Medicine for Older Persons Clinical Nurse Specialist, Physiotherapist/Occupational Therapist, Consultant Geriatrician and Geriatric Medicine Registrar. Each team in the hospital are requested to attend at least twice a week. Predicted discharge dates are established. Teams discuss patients who have a requirement for rehabilitation, either short-term or complex rehabilitation and patients over 65 years who may need review from Older Persons Services .We sought to optimise issues including housing, home care packages, interim home supports, community intervention team referrals, integrated care and Nursing Home Support Scheme applications.
Results
There were 3918 Emergency Department presentations by adults over 75 in 2018 and 2113 admissions (3704, 2081 respectively in 2017). Accuracy for discharge within one day of PDD ranged from 52.5% (Jan) to 72.6 % (Nov). The average length of stay was 6.2days (SD 0.47). 172 patients (84 female, 88 male) were admitted for slow stream rehabilitation (median length of stay 30 days).
Conclusion
Rather than using a negative view of older adults as potential ‘bed blockers’, the discharge huddle allowed a pro-active approach to assist medical and surgical teams in the management and re-enablement of patients with complex care needs. Early identification of such patients with complex care and discharge needs allowed greater focus on appropriate planning earlier in the patient’s hospital journey.
Collapse
|
4
|
Quattrocchi A, Mereckiene J, Fitzgerald M, Cotter S. Determinants of influenza and pertussis vaccine uptake in pregnant women in Ireland: A cross-sectional survey in 2017/18 influenza season. Vaccine 2019; 37:6390-6396. [PMID: 31515147 DOI: 10.1016/j.vaccine.2019.09.008] [Citation(s) in RCA: 12] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/29/2019] [Revised: 09/02/2019] [Accepted: 09/04/2019] [Indexed: 10/26/2022]
Abstract
In Ireland seasonal influenza and pertussis vaccination during pregnancy is recommended and every year national campaigns are organised to raise awareness and improve uptake. We estimated influenza and pertussis vaccine uptake and identified factors associated with vaccination status in pregnant women in 2017/18. We conducted a face-to-face omnibus survey, with quota sampling, among women aged 18-55 years and collected socio-demographic characteristics, self-reported vaccination status, awareness of vaccine campaigns, and attitudes towards vaccination. Sample was weighted to ensure representativeness with the target population. We performed univariate and multivariable logistic regression analyses on survey data. Overall, 241 pregnant women were enrolled. Influenza and pertussis vaccine uptake was 61.7% and 49.9%, respectively. Awareness of vaccine campaign and socio-economic status (SES) were associated with both influenza and pertussis vaccine uptake. The association between SES and uptake of vaccines differed by awareness. Women aware of the influenza vaccine campaign and with mid and low SES were less likely to be vaccinated, compared to those with high SES (aOR = 0.46; 95%CI: 0.22-0.97; aOR = 0.27; 95%CI: 0.12-0.60, respectively); women not aware of the pertussis vaccine campaign and with mid and low SES were less likely to be vaccinated, compared to those aware and with high SES (aOR = 0.15; 95%CI: 0.04-0.48; aOR = 0.05; 95%CI: 0.01-0.24, respectively). General practitioner (GP) recommendation was the main reason for receiving influenza vaccine (39.2%), and 71.8% of women were recommended pertussis vaccination from their GPs. The survey reports moderate uptake of vaccines among pregnant women, inequalities in uptake by SES and identifies GPs as primary source for vaccine recommendation. We recommend multifaceted campaigns, by engaging GPs, to target all socio-economic groups.
Collapse
Affiliation(s)
- A Quattrocchi
- Health Protection Surveillance Centre, Dublin, Ireland; European Programme for Intervention Epidemiology Training, Stockholm, Sweden
| | - J Mereckiene
- Health Protection Surveillance Centre, Dublin, Ireland.
| | - M Fitzgerald
- Health Protection Surveillance Centre, Dublin, Ireland
| | - S Cotter
- Health Protection Surveillance Centre, Dublin, Ireland
| |
Collapse
|
5
|
Corcoran M, Mereckiene J, Murchan S, McElligott M, ’Flanagan D, Cotter S, Cunney R, Humphreys H. Is It Time To Review The Vaccination Strategy To Protect Adults Against Invasive Pneumococcal Disease? Ir Med J 2019; 112:894. [PMID: 30968681] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/09/2023]
Abstract
Pneumococcal conjugate vaccines (PCVs) have reduced the predominant serotypes causing invasive pneumococcal disease (IPD). We assessed the impact of the paediatric 7- and 13-valent pneumococcal conjugate vaccines (PCV7 and PCV13) among older adults. We compared serotype-specific incidence rates from 2007/08 to 2016/17, expressed as incidence rate ratios (IRR). Introducing PCV7 and PCV13 into the childhood immunisation programme resulted in a decline in these serotypes in adults ≥65 years of age, with PCV7 serotypes decreasing by 85% (IRR=0.11, 95%CI: 0.05-0.22, p<0.0001) and PCV13 serotypes not included in PCV7 (PCV13-7), decreasing by 9% (IRR=0.68, 95%CI: 0.40-1.16, p=0.134). However, there was a significant increase in serotypes only found in the 23-valent polysaccharide vaccine, PPV23-PCV13: IRR=2.57, 95%CI: 1.68-4.03, p<0.0001, and non-vaccine types (NVTs), IRR=3.33, 95%CI: 1.75-6.84, p=0.0001. The decline of IPD associated with PCV7/13 serotypes and the increase in PPV23-PCV13 serotypes indicates clear serotype replacement. Increasing PPV23 uptake could still reduce the burden of disease for this population.
Collapse
Affiliation(s)
- M Corcoran
- The Irish Pneumococcal Reference Laboratory, Irish Meningitis and Sepsis Reference Laboratory, Temple Street Children’s University Hospital, Temple Street, Dublin 1, Ireland
| | - J Mereckiene
- Health Protection Surveillance Centre, Dublin, Gardiner Street, Dublin 1, Ireland
| | - S Murchan
- Health Protection Surveillance Centre, Dublin, Gardiner Street, Dublin 1, Ireland
| | - M McElligott
- The Irish Pneumococcal Reference Laboratory, Irish Meningitis and Sepsis Reference Laboratory, Temple Street Children’s University Hospital, Temple Street, Dublin 1, Ireland
- Department of Clinical Microbiology, the Royal College of Surgeons in Ireland, RCSI Education & Research Centre, Beaumont Hospital, Beaumont, Dublin 9, Ireland
| | - D ’Flanagan
- Health Protection Surveillance Centre, Dublin, Gardiner Street, Dublin 1, Ireland
| | - S Cotter
- Health Protection Surveillance Centre, Dublin, Gardiner Street, Dublin 1, Ireland
| | - R Cunney
- The Irish Pneumococcal Reference Laboratory, Irish Meningitis and Sepsis Reference Laboratory, Temple Street Children’s University Hospital, Temple Street, Dublin 1, Ireland
- Health Protection Surveillance Centre, Dublin, Gardiner Street, Dublin 1, Ireland
- Department of Microbiology, Temple Street Children’s University Hospital, Dublin 1, Ireland
| | - H Humphreys
- The Irish Pneumococcal Reference Laboratory, Irish Meningitis and Sepsis Reference Laboratory, Temple Street Children’s University Hospital, Temple Street, Dublin 1, Ireland
- Department of Clinical Microbiology, the Royal College of Surgeons in Ireland, RCSI Education & Research Centre, Beaumont Hospital, Beaumont, Dublin 9, Ireland
- Department of Microbiology, Beaumont Hospital, Beaumont, Dublin 9, Ireland
| |
Collapse
|
6
|
Chaintarli K, Barrassa A, Cotter S, Mereckiene J, O'Donnell J, Domegan L. Decrease in the Uptake of Seasonal Influenza Vaccine in Persons Aged 65 Years and Older In Ireland since the 2009 Influenza A (H1N1) Pdm09 Pandemic. Ir Med J 2017; 110:630. [PMID: 29372945] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/07/2023]
Abstract
In Ireland, there is year-on-year variation in the seasonal influenza vaccine uptake for people aged 65 years and older. We obtained aggregate vaccine uptake data (2004/05-2014/15) by area and age group and applied the 2011 relative deprivation score and GP-density by area. Using Poisson regression model, we estimated the associations between those variables and uptake before and after the 2009 pandemic. After adjusting for age, deprivation status and GP-density, overall persons aged ?65 years were less likely to receive the vaccine after the pandemic compared to before (RR=0.89, 95%CI: 0.82-0.96). Uptake increased with age; both those in the 70-74 and ?75 year age groups were more likely to receive the vaccine compared to those aged 65-69 years (RR=1.18, 95%CI:1.14-1.24; RR=1.34, 95%CI:1.28-1.39 respectively). Qualitative studies should be undertaken to explore whether changes in public perception on risks of the disease and the vaccine and/or public funding and policy influenced the uptake.
Collapse
Affiliation(s)
- K Chaintarli
- European Programme for Intervention Epidemiology Training (EPIET), European Centre for Disease Prevention and Control, (ECDC), Solna, Sweden
- Health Protection Surveillance Centre, Dublin, Ireland
| | - A Barrassa
- European Programme for Intervention Epidemiology Training (EPIET), European Centre for Disease Prevention and Control, (ECDC), Solna, Sweden
- Institute of Health Carlos III, Spain
| | - S Cotter
- Health Protection Surveillance Centre, Dublin, Ireland
| | - J Mereckiene
- Health Protection Surveillance Centre, Dublin, Ireland
| | - J O'Donnell
- Health Protection Surveillance Centre, Dublin, Ireland
| | - L Domegan
- Health Protection Surveillance Centre, Dublin, Ireland
| |
Collapse
|
7
|
Migone C, Barrett T, Cotter S, Clarke A, Corcoran B. The Uptake of Human Papillomavirus Vaccine In Irish Schools: The Impact Of Disadvantage. Ir Med J 2017; 110:603. [PMID: 29341515] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/07/2023]
Abstract
HPV vaccine Gardasil© is offered to girls in first year of secondary school in Ireland. We aimed to determine the association between HPV vaccine uptake among girls for academic year 2013/2014, by school and school characteristics: socioeconomic disadvantage and religious ethos. The National Schools Immunisation System (SIS) was searched to determine HPV vaccine uptake in schools for 2013/2014 (prior to recent anti-HPV vaccine publicity). The disadvantaged status and ethos of each school was added to the report. In total 577 schools were identified. Mean vaccine uptake was 83.7%. Disadvantaged schools had a lower mean uptake (%) than other schools (79.4% vs 85.0%, difference 5.58%, 95%CI 2.69-8.21) and were twice as likely to have an uptake of ?50% (OR 2.07, 95% CI 2.76 - 5.18). No difference was found between schools of different ethoses. HPV vaccine uptake is lower in disadvantaged Irish schools. Policies should be developed to ensure a more equitable uptake of HPV vaccine.
Collapse
Affiliation(s)
- C Migone
- Department of Public Health, Health Service Executive-East, Dr Steevens' Hospital, Dublin 8, Ireland
| | - T Barrett
- National Immunisation Office, Units 8-9 Manor Street Business Park, Manor Street, Dublin 7, Ireland
| | - S Cotter
- Health Protection Surveillance Centre, 25-27 Middle Gardiner Street, Dublin 1, Ireland
| | - A Clarke
- National Immunisation Office, Units 8-9 Manor Street Business Park, Manor Street, Dublin 7, Ireland
| | - B Corcoran
- National Immunisation Office, Units 8-9 Manor Street Business Park, Manor Street, Dublin 7, Ireland
| |
Collapse
|
8
|
Calvert SJ, Longtine MS, Cotter S, Jones CJP, Sibley CP, Aplin JD, Nelson DM, Heazell AEP. Studies of the dynamics of nuclear clustering in human syncytiotrophoblast. Reproduction 2016; 151:657-71. [PMID: 27002000 PMCID: PMC4911178 DOI: 10.1530/rep-15-0544] [Citation(s) in RCA: 18] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/24/2015] [Accepted: 03/21/2016] [Indexed: 11/29/2022]
Abstract
Syncytial nuclear aggregates (SNAs), clusters of nuclei in the syncytiotrophoblast of
the human placenta, are increased as gestation advances and in pregnancy pathologies.
The origins of increased SNAs are unclear; however, a better appreciation of the
mechanism may give insight into placental ageing and factors underpinning
dysfunction. We developed three models to investigate whether SNA formation results
from a dynamic process of nuclear movement and to generate alternative hypotheses.
SNA count and size were measured in placental explants cultured over 16 days and
particles released into culture medium were quantified. Primary trophoblasts were
cultured for 6 days. Explants and trophoblasts were cultured with and without
cytoskeletal inhibitors. An in silico model was developed to examine
the effects of modulating nuclear behaviour on clustering. In explants, neither
median SNA number (108 SNA/mm2 villous area) nor size (283
μm2) changed over time. Subcellular particles from conditioned
culture medium showed a wide range of sizes that overlapped with those of SNAs.
Nuclei in primary trophoblasts did not change position relative to other nuclei;
apparent movement was associated with positional changes of the syncytial cell
membrane. In both models, SNAs and nuclear clusters were stable despite
pharmacological disruption of cytoskeletal activity. In silico,
increased nuclear movement, adhesiveness and sites of cytotrophoblast fusion were
related to nuclear clustering. The prominence of SNAs in pregnancy disorders may not
result from an active process involving cytoskeleton-mediated rearrangement of
syncytial nuclei. Further insights into the mechanism(s) of SNA formation will aid
understanding of their increased presence in pregnancy pathologies.
Collapse
Affiliation(s)
- S J Calvert
- Maternal and Fetal Health Research CentreInstitute of Human Development, School of Medicine, University of Manchester, Manchester, UK St Mary's HospitalCentral Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK
| | - M S Longtine
- Department of Obstetrics and GynecologyWashington University School of Medicine, St Louis, Missouri, USA
| | - S Cotter
- School of MathematicsAlan Turing Building, University of Manchester, Manchester, UK
| | - C J P Jones
- Maternal and Fetal Health Research CentreInstitute of Human Development, School of Medicine, University of Manchester, Manchester, UK St Mary's HospitalCentral Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK
| | - C P Sibley
- Maternal and Fetal Health Research CentreInstitute of Human Development, School of Medicine, University of Manchester, Manchester, UK St Mary's HospitalCentral Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK
| | - J D Aplin
- Maternal and Fetal Health Research CentreInstitute of Human Development, School of Medicine, University of Manchester, Manchester, UK St Mary's HospitalCentral Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK
| | - D M Nelson
- Department of Obstetrics and GynecologyWashington University School of Medicine, St Louis, Missouri, USA
| | - A E P Heazell
- Maternal and Fetal Health Research CentreInstitute of Human Development, School of Medicine, University of Manchester, Manchester, UK St Mary's HospitalCentral Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK
| |
Collapse
|
9
|
Flanagan P, O'Lorcain P, Cotter S, Connell J, Lynch B, Cunney R, O'Flanagan D. Reporting of Acute Flaccid Paralysis in Children under 15 years of age: Improving Surveillance, January 2009 - December 2014. Ir Med J 2016; 109:357. [PMID: 27685691] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Subscribe] [Scholar Register] [Indexed: 06/06/2023]
Abstract
Acute Flaccid Paralysis (AFP) surveillance, including case investigation and specimen collection is a gold standard method for poliomyelitis surveillance. The expected annual non-polio AFP rate <15 years of age in Ireland is = 1/100 000 population. This study reviewed all cases of AFP reported to the Irish Paediatric Surveillance Unit and the Health Protection Surveillance Centre between January 2009 and December 2014 and compared reporting rates with the expected incidence rate annually. We assessed quality of surveillance data in terms of completeness of investigation for each case reported. Forty-three AFP cases in children <15 years were notified; 35 of which were confirmed. Guillain-Barre Syndrome (GBS) accounted for 48.6% (n=17) of AFP notifications. In 2014, the expected annual AFP target rate was reached. This study identified possible under-reporting of AFP paediatric cases in Ireland between 2009-2013. Completeness of investigations has improved over time, but requires further work.
Collapse
Affiliation(s)
- P Flanagan
- Health Protection Surveillance Centre, 25-27 Middle Gardiner St, Dublin 1
| | - P O'Lorcain
- Health Protection Surveillance Centre, 25-27 Middle Gardiner St, Dublin 1
| | - S Cotter
- Health Protection Surveillance Centre, 25-27 Middle Gardiner St, Dublin 1
| | - J Connell
- National Virus Reference Laboratory, UCD, Belfield, Dublin 4
| | - B Lynch
- Department of Paediatric Neurology, Childrens University Hospital, Temple St, Dublin 1
| | - R Cunney
- Health Protection Surveillance Centre, 25-27 Middle Gardiner St, Dublin 1
| | - D O'Flanagan
- Health Protection Surveillance Centre, 25-27 Middle Gardiner St, Dublin 1
| |
Collapse
|
10
|
O'Connor L, Ward M, Bennett D, Mulhall R, O'Lorcain P, Cunney R, McDermott R, Neville E, Heslin J, FitzGerald R, Meyler K, Conlon M, Clarke A, Corcoran B, Fitzpatrick G, O'Connor B, Flanagan P, O'Flanagan D, Cotter S. A prolonged outbreak of invasive meningococcal disease in an extended Irish Traveller family across three Health Service Executive (HSE) areas in Ireland, 2010 to 2013. ACTA ACUST UNITED AC 2015; 20. [PMID: 26062560 DOI: 10.2807/1560-7917.es2015.20.21.21139] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
Abstract
Between March 2010 and November 2013 eight laboratory-confirmed cases of serogroup B, invasive meningococcal disease (IMD) were identified in an extended Irish Traveller family across three Health Service Executive (HSE) areas of Ireland. Cases were aged between 5 and 46 months, and were either a cousin or sibling of another case. All eight cases survived. Chemoprophylaxis was given to relevant nuclear family members and close contacts on each occasion, but failed to prevent further cases. Neisseria meningitidis isolates from six cases were highly related, belonging to the ST-41/44 clonal complex, and shared the porA designation 7–2,4. In November 2013, the outbreak control team recommended that directly observed ciprofloxacin chemoprophylaxis be administered simultaneously to the extended family, and that the four component meningococcal B (4CMenB) vaccine be administered to family members aged 2 months to 23 years inclusive and relevant close contacts of the eighth case. Subsequently these recommendations were implemented at three regional clinics. Additionally pharyngeal swabs (n=112) were collected to assess carriage rates of N. meningitidis in this extended family. Pharyngeal carriage of N. meningitidis was detected in 15 (13%) family members. From the epidemiological investigation and carriage study overcrowding was the most likely risk factor identified in this outbreak. To date, the combination of directly observed ciprofloxacin chemoprophylaxis and use of 4CMenB vaccine have controlled the outbreak with no further cases diagnosed.
Collapse
Affiliation(s)
- L O'Connor
- Department of Public Health, HSE East, Dr Steevens Hospital, Dublin, Ireland
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
11
|
Hardy WD, Hess PW, Essex M, Cotter S, McClelland AJ, MacEwen G. Horizontal transmission of feline leukemia virus in cats. Bibl Haematol 2015:67-74. [PMID: 169834 DOI: 10.1159/000397519] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
Abstract
Traditionally, cancer has not been considered an infectious disease although some multiple cases of leukemia in man and cattle have been reported. The discovery that feline lymphosarcoma was associated with an RNA virus (feline leukemia virus(FeLV)) meant that infectious transmission of the disease was a possibility. The critical question was whether the predominant method of transmission from one animal to another was 'vertical' (via the gametes) or 'horizontal' (via contagion or infection). A number of epidemiological studies have shown that the chances of healthy cats contracting lymphosarcoma are greatly increased when a cat with the disease lives in close proximity. It does not matter whether the healthy cats are related to the sick animal or not. It has also been established that viremic normal cats have an approximately 900 times greater chance of developing leukemia than cats whose FeLV status is unknown. Infectious FeLV is present in the excretions and blood of viremic animals. In the natural environment, feline lymphosarcoma occurs in clusters. The results in pet cats have been supported by experiments with cat colonies under controlled conditions and prove that horizontal transmission of FeLV occurs. This does not mean that epigenetic (infection in utero or via the milk) or vertical transmission cannot also occur. It should be possible to break the cycle of horizontal transmission of the virus by vaccination and thus control FeLV-related diseases.
Collapse
|
12
|
Takla A, Wichmann O, Carrillo-Santisteve P, Cotter S, Lévy-Bruhl D, Paradowska-Stankiewicz I, Valentiner-Branth P, D’Ancona F, the VENICE III NITAG Survey Group C. Characteristics and practices of National Immunisation Technical Advisory Groups in Europe and potential for collaboration, April 2014. Euro Surveill 2015; 20. [DOI: 10.2807/1560-7917.es2015.20.9.21049] [Citation(s) in RCA: 19] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/08/2023] Open
Abstract
Binary file ES_Abstracts_Final_ECDC.txt matches
Collapse
Affiliation(s)
- A Takla
- Robert Koch Institute, Berlin, Germany
| | | | | | - S Cotter
- Health Protection Surveillance Centre, Dublin, Ireland
| | - D Lévy-Bruhl
- Institut de Veille Sanitare, Saint-Maurice, France
| | | | | | - F D’Ancona
- Istituto Superiore di Sanitá, Rome, Italy
| | | |
Collapse
|
13
|
Thompson ND, Novak RT, Datta D, Cotter S, Arduino MJ, Patel PR, Williams IT, Bialek SR. Hepatitis C Virus Transmission in Hemodialysis Units Importance of Infection Control Practices and Aseptic Technique. Infect Control Hosp Epidemiol 2015; 30:900-3. [PMID: 19642900 DOI: 10.1086/605472] [Citation(s) in RCA: 42] [Impact Index Per Article: 4.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/12/2022]
Abstract
We investigated 4 hepatitis C virus (HCV) infection outbreaks at hemodialysis units to identify practices associated with transmission. Apparent failures to follow recommended infection control precautions resulted in patient-to-patient HCV transmission, through cross-contamination of the environment or intravenous medication vials. Fastidious attention to aseptic technique and infection control precautions are essential to prevent HCV transmission.
Collapse
Affiliation(s)
- Nicola D Thompson
- National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA.
| | | | | | | | | | | | | | | |
Collapse
|
14
|
O'Lorcain P, Cotter S, O'Flanaqan D, Corcoran B, O'Meara M. Author response. Ir Med J 2014; 107:301. [PMID: 25417399] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/04/2023]
|
15
|
O'Flanagan D, Barret AS, Foley M, Cotter S, Bonner C, Crowe C, Lynch B, Sweeney B, Johnson H, McCoy B, Purcell E. Investigation of an association between onset of narcolepsy and vaccination with pandemic influenza vaccine, Ireland April 2009-December 2010. Euro Surveill 2014; 19:15-25. [PMID: 24821121] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/03/2023] Open
Abstract
In 2011, the Irish Medicines Board received reports of onset of narcolepsy following vaccination against influenza A(H1N1)pdm09 with Pandemrix. A national steering committee was convened to examine the association between narcolepsy and pandemic vaccination. We conducted a retrospective population-based cohort study. Narcolepsy cases with onset from 1 April 2009 to 31 December 2010 were identified through active case finding. Narcolepsy history was gathered from medical records. Pandemic vaccination status was obtained from vaccination databases. Two independent experts classified cases using the Brighton case definition. Date of onset was defined as date of first healthcare contact for narcolepsy symptoms. Incidence of narcolepsy in vaccinated and non-vaccinated individuals was compared. Of 32 narcolepsy cases identified, 28 occurred in children/adolescents and for 24 first healthcare contact was between April 2009 and December 2010. Narcolepsy incidence was 5.7 (95% confidence interval (CI): 3.4–8.9) per 100,000 children/adolescents vaccinated with Pandemrix and 0.4 (95% CI: 0.1–1.0) per 100,000 unvaccinated children/adolescents (relative risk: 13.9; absolute attributable risk: 5.3 cases per 100,000 vaccinated children/adolescents). This study confirms the crude association between Pandemrix vaccination and narcolepsy as observed in Finland and Sweden. The vaccine is no longer in use in Ireland. Further studies are needed to explore the immunogenetic mechanism of narcolepsy.
Collapse
Affiliation(s)
- D O'Flanagan
- Health Service Executive, Health Protection Surveillance Centre, Dublin, Ireland
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
16
|
O’Flanagan D, Barret AS, Foley M, Cotter S, Bonner C, Crowe C, Lynch B, Sweeney B, Johnson H, McCoy B, Purcell E. Investigation of an association between onset of narcolepsy and vaccination with pandemic influenza vaccine, Ireland April 2009-December 2010. Euro Surveill 2014. [DOI: 10.2807/1560-7917.es2014.19.17.20789] [Citation(s) in RCA: 43] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
Binary file ES_Abstracts_Final_ECDC.txt matches
Collapse
Affiliation(s)
- D O’Flanagan
- Health Service Executive, Health Protection Surveillance Centre, Dublin, Ireland
- These authors contributed equally to this manuscript
| | - A S Barret
- These authors contributed equally to this manuscript
- Health Service Executive, Health Protection Surveillance Centre, Dublin, Ireland
| | - M Foley
- Health Service Executive, Health Protection Surveillance Centre, Dublin, Ireland
| | - S Cotter
- Health Service Executive, Health Protection Surveillance Centre, Dublin, Ireland
| | - C Bonner
- Department of Health, Dublin, Ireland
| | - C Crowe
- Mater Private Hospital, Dublin, Ireland
| | - B Lynch
- Children’s University Hospital Temple Street, Dublin, Ireland
| | - B Sweeney
- Cork University Hospital, Cork, Ireland
| | - H Johnson
- Health Service Executive, Health Intelligence Unit, Dublin, Ireland
| | - B McCoy
- Our Lady’s Children’s Hospital, Crumlin, Dublin, Ireland
| | - E Purcell
- Mater Private Hospital, Dublin, Ireland
| |
Collapse
|
17
|
Mereckiene J, Cotter S, Nicoll A, Lopalco P, Noori T, Weber J, D'Ancona F, Levy-Bruhl D, Dematte L, Giambi C, Valentiner-Branth P, Stankiewicz I, Appelgren E, O Flanagan D. Seasonal influenza immunisation in Europe. Overview of recommendations and vaccination coverage for three seasons: pre-pandemic (2008/09), pandemic (2009/10) and post-pandemic (2010/11). ACTA ACUST UNITED AC 2014; 19:20780. [PMID: 24786262 DOI: 10.2807/1560-7917.es2014.19.16.20780] [Citation(s) in RCA: 132] [Impact Index Per Article: 13.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
Abstract
Since 2008, annual surveys of influenza vaccination policies, practices and coverage have been undertaken in 29 European Union (EU)/ European Economic Area (EEA) countries. After 2009, this monitored the impact of European Council recommendation to increase vaccination coverage to 75% among risk groups. This paper summarises the results of three seasonal influenza seasons: 2008/09, 2009/10 and 2010/11. In 2008/09, 27/29 countries completed the survey; in 2009/10 and 2010/11, 28/29 completed it. All or almost all countries recommended vaccination of older people (defined as those aged ≥50, ≥55, ≥59, ≥60 or ≥65 years), and people aged ≥6 months with clinical risk and healthcare workers. A total of 23 countries provided vaccination coverage data for older people, but only 7 and 10 had data for the clinical risk groups and healthcare workers, respectively. The number of countries recommending vaccination for some or all pregnant women increased from 10 in 2008/09 to 22 in 2010/11. Only three countries could report coverage among pregnant women. Seasonal influenza vaccination coverage during and after the pandemic season in older people and clinical groups remained unchanged in countries with higher coverage. However, small decreases were seen in most countries during this period. The results of the surveys indicate that most EU/EEA countries recommend influenza vaccination for the main target groups; however, only a few countries have achieved the target of 75% coverage among risk groups. Coverage among healthcare workers remained low.
Collapse
Affiliation(s)
- J Mereckiene
- Health Protection Surveillance Centre, Dublin, Ireland
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
18
|
O'Lorcain P, Cotter S, Hickey L, O'Flanagan D, Corcoran B, O'Meara M. Seasonal influenza vaccine uptake in HSE-funded hospitals and nursing homes during the 2011/2012 influenza season. Ir Med J 2014; 107:74-77. [PMID: 24757889] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/03/2023]
Abstract
Annual seasonal influenza vaccine is recommended for all health care workers (HCWs) in Ireland. For the 2011/2012 influenza season, information was collected on influenza vaccination uptake among HCWs employed in Health Service Executive (HSE)-funded hospitals (primarily acute) and of nursing homes (NHs) and also among NH long-term and short-term respite care residents. Forty-five hospitals (80%) and 120 NHs (75%) provided uptake data. Nationally, influenza vaccine uptake among hospital employed HCWs was estimated to be 18% and 14% among HCWs in NHs; in NHs vaccine uptake among long-term care residents was estimated to 88%. These findings highlight the continued low uptake among HCWs of all categories and demonstrate the need for sustained measures to improve uptake rates.
Collapse
|
19
|
Fitzpatrick G, Ward M, Ennis O, Johnson H, Cotter S, Carr MJ, O Riordan B, Waters A, Hassan J, Connell J, Hall W, Clarke A, Murphy H, Fitzgerald M. Use of a geographic information system to map cases of measles in real-time during an outbreak in Dublin, Ireland, 2011. ACTA ACUST UNITED AC 2012; 17. [PMID: 23231894 DOI: 10.2807/ese.17.49.20330-en] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
Abstract
In 2011, there was a large measles outbreak in Dublin. Nationally 285 cases were notified to the end of December 2011, and 250 (88%) were located in the Dublin region. After the first case was notified in week 6, numbers gradually increased, with 25 notified in June and a peak of 53 cases in August. Following public health intervention including a measles-mumps-rubella (MMR) vaccination campaign, no cases were reported in the Dublin region in December 2011. Most cases (82%) were children aged between 6 months and 14 years, and 46 cases (18%) were under 12 months-old. This is the first outbreak in Dublin to utilise a geographic information system for plotting measles cases on a digital map in real time. This approach, in combination with the analysis of case notifications, assisted the department of public health in demonstrating the extent of the outbreak. The digital mapping documented the evolution of two distinct clusters of 87 (35%) cases. These measles cases were infected with genotype D4-Manchester recently associated with large outbreaks across Europe. The two clusters occurred in socio-economically disadvantaged areas and were attributable to inadequate measles vaccination coverage due in part to the interruption of a school-based MMR2 vaccination programme.
Collapse
Affiliation(s)
- G Fitzpatrick
- Department of Public Health, Health Service Executive (HSE) East, Dr Steeven's Hospital, Dublin, Ireland.
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
20
|
Mereckiene J, Cotter S, Weber JT, Nicoll A, D'Ancona F, Lopalco PL, Johansen K, Wasley AM, Jorgensen P, Lévy-Bruhl D, Giambi C, Stefanoff P, Dematte L, O'Flanagan D. Influenza A(H1N1)pdm09 vaccination policies and coverage in Europe. ACTA ACUST UNITED AC 2012; 17. [PMID: 22297139 DOI: 10.2807/ese.17.04.20064-en] [Citation(s) in RCA: 73] [Impact Index Per Article: 6.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
Abstract
In August 2010 the Vaccine European New Integrated Collaboration Effort (VENICE) project conducted a survey to collect information on influenza A(H1N1)pdm09 vaccination policies and vaccination coverage in the European Union (EU), Norway and Iceland. Of 29 responding countries, 26 organised national pandemic influenza vaccination and one country had recommendations for vaccination but did not have a specific programme. Of the 27 countries with vaccine recommendations, all recommended it for healthcare workers and pregnant women. Twelve countries recommended vaccine for all ages. Six and three countries had recommendations for specific age groups in children and in adults, countries for specific adult age groups. Most countries recommended vaccine for those in new risk groups identified early in the pandemic such as morbid obese and people with neurologic diseases. Two thirds of countries started their vaccination campaigns within a four week period after week 40/2009. The reported vaccination coverage varied between countries from 0.4% to 59% for the entire population (22 countries); 3% to 68% for healthcare workers (13 countries); 0% to 58% for pregnant women (12 countries); 0.2% to 74% for children (12 countries). Most countries identified similar target groups for pandemic vaccine, but substantial variability in vaccination coverage was seen. The recommendations were in accordance with policy advice from the EU Health Security Committee and the World Health Organization.
Collapse
Affiliation(s)
- J Mereckiene
- Health Protection Surveillance Centre, Dublin, Ireland.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
21
|
Dorleans F, Giambi C, Dematte L, Cotter S, Stefanoff P, Mereckiene J, O'Flanagan D, Lopalco PL, D'Ancona F, Levy-Bruhl D. The current state of introduction of human papillomavirus vaccination into national immunisation schedules in Europe: first results of the VENICE2 2010 survey. ACTA ACUST UNITED AC 2010; 15. [PMID: 21144444 DOI: 10.2807/ese.15.47.19730-en] [Citation(s) in RCA: 74] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
Abstract
The Venice 2 human papillomavirus vaccination survey evaluates the state of introduction of the HPV vaccination into the national immunisation schedules in the 29 participating countries. As of July 2010, 18 countries have integrated this vaccination. The vaccination policy and achievements vary among those countries regarding target age groups, delivery infrastructures and vaccination coverage reached. Financial constraints remain the major obstacle for the 11 countries who have not yet introduced the vaccination.
Collapse
Affiliation(s)
- F Dorleans
- Department of Infectious Diseases, Institut de Veille Sanitaire (InVS, French Institute for Public Health Surveillance), Paris, France.
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
22
|
Mereckiene J, Cotter S, D'Ancona F, Giambi C, Nicoll A, Lévy-Bruhl D, Lopalco PL, Weber JT, Johansen K, Dematte L, Salmaso S, Stefanoff P, Greco D, Dorleans F, Polkowska A, O’Flanagan D, on behalf of the VENICE project gatekeepers group. Differences in national influenza vaccination policies across the European Union, Norway and Iceland 2008-2009. Euro Surveill 2010; 15. [DOI: 10.2807/ese.15.44.19700-en] [Citation(s) in RCA: 100] [Impact Index Per Article: 7.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
In 2009 the second cross-sectional web-based survey was undertaken by the Vaccine European New Integrated Collaboration Effort (VENICE) project across 27 European Union (EU) member states (MS), Norway and Iceland (n=29) to determine changes in official national seasonal influenza vaccination policies since a survey undertaken in 2008 and to compare the estimates of vaccination coverage between countries using data obtained from both surveys. Of 27 responding countries, all recommended vaccination against seasonal influenza to the older adult population. Six countries recommended vaccination of children aged between six months and <18 years old. Most countries recommended influenza vaccination for those individuals with chronic medical conditions. Recommendations for vaccination of healthcare workers (HCW) in various settings existed in most, but not all countries. Staff in hospitals and long-term care facilities were recommended vaccination in 23 countries, and staff in out-patient clinics in 22 countries. In the 2009 survey, the reported national estimates on vaccine coverage varied by country and risk group, ranging from 1.1% - 82.6% for the older adult population; to between 32.9% -71.7% for clinical risk groups; and from 13.4% -89.4% for HCW. Many countries that recommend the influenza vaccination do not monitor the coverage in risk groups. In 2008 and 2009 most countries recommended influenza vaccination for the main risk groups. Hovewer, despite general consensus and recommendations for vaccination of high risk groups many countries do not achieve high coverage in these groups. The reported vaccination coverage still needs to be improved in order to achieve EU and World Health Organization goals.
Collapse
Affiliation(s)
- J Mereckiene
- Vaccine European New Integrated Collaboration Effort (VENICE) Project
- Health Protection Surveillance Centre, Dublin, Ireland
| | - S Cotter
- Health Protection Surveillance Centre, Dublin, Ireland
- Vaccine European New Integrated Collaboration Effort (VENICE) Project
| | - F D'Ancona
- Vaccine European New Integrated Collaboration Effort (VENICE) Project
- Istituto Superiore di Sanitá, Rome, Italy
| | - C Giambi
- Istituto Superiore di Sanitá, Rome, Italy
- Vaccine European New Integrated Collaboration Effort (VENICE) Project
| | - A Nicoll
- European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden
| | - D Lévy-Bruhl
- Institut de Veille Sanitare, Saint-Maurice, France
- Vaccine European New Integrated Collaboration Effort (VENICE) Project
| | - P L Lopalco
- European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden
| | - J T Weber
- European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden
| | - K Johansen
- European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden
| | - L Dematte
- Vaccine European New Integrated Collaboration Effort (VENICE) Project
- CINECA Consortium of Universities, Bologna, Italy
| | - S Salmaso
- Istituto Superiore di Sanitá, Rome, Italy
- Vaccine European New Integrated Collaboration Effort (VENICE) Project
| | - P Stefanoff
- Vaccine European New Integrated Collaboration Effort (VENICE) Project
- National Institute of Public Health - National Institute of Hygiene, Warsaw, Poland
| | - D Greco
- Vaccine European New Integrated Collaboration Effort (VENICE) Project
- Istituto Superiore di Sanitá, Rome, Italy
| | - F Dorleans
- Vaccine European New Integrated Collaboration Effort (VENICE) Project
- Institut de Veille Sanitare, Saint-Maurice, France
| | - A Polkowska
- Vaccine European New Integrated Collaboration Effort (VENICE) Project
- National Institute of Public Health - National Institute of Hygiene, Warsaw, Poland
| | - D O’Flanagan
- Health Protection Surveillance Centre, Dublin, Ireland
- Vaccine European New Integrated Collaboration Effort (VENICE) Project
| | | |
Collapse
|
23
|
Abstract
We report a community pertussis outbreak that occurred in a small town located in the northwest of Ireland. Epidemiological investigations suggest that waning immunity and the absence of a booster dose during the second year of life could have contributed to the outbreak. The report also highlights the need to reinforce the surveillance of pertussis in Ireland and especially to improve the clinical and laboratory diagnosis of cases.
Collapse
Affiliation(s)
- A S Barret
- European Programme for Intervention Epidemiology Training (EPIET), European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden
- Health Protection Surveillance Centre (HPSC), Dublin, Ireland
| | - A Ryan
- Department of Public Health, Health Services Executive North West, Sligo, Ireland
| | - A Breslin
- Department of Public Health, Health Services Executive North West, Sligo, Ireland
| | - L Cullen
- Department of Public Health, Health Services Executive North West, Sligo, Ireland
| | - A Murray
- Department of Public Health, Health Services Executive North West, Sligo, Ireland
| | - J Grogan
- Our Lady’s Sick Children’s Hospital (OLSCH), Crumlin, Dublin, Ireland
| | - S Bourke
- Aghadark General Practice, Ballinamore, Ireland
| | - S Cotter
- Health Protection Surveillance Centre (HPSC), Dublin, Ireland
| |
Collapse
|
24
|
Barret AS, Ryan A, Breslin A, Cullen L, Murray A, Grogan J, Bourke S, Cotter S. Pertussis outbreak in northwest Ireland, January - June 2010. Euro Surveill 2010; 15:19654. [PMID: 20822735] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/29/2023] Open
Abstract
We report a community pertussis outbreak that occurred in a small town located in the northwest of Ireland. Epidemiological investigations suggest that waning immunity and the absence of a booster dose during the second year of life could have contributed to the outbreak. The report also highlights the need to reinforce the surveillance of pertussis in Ireland and especially to improve the clinical and laboratory diagnosis of cases.
Collapse
Affiliation(s)
- A S Barret
- Health Protection Surveillance Centre (HPSC), Dublin, Ireland.
| | | | | | | | | | | | | | | |
Collapse
|
25
|
Abstract
Measles cases are increasing in Ireland, with 320 cases notified since August 2009. Nearly two-thirds of these cases (n=206) were unvaccinated. In the early stages of the outbreak a substantial number of cases were linked to the Traveller community with some cases also reported among the Roma community, other citizens from eastern Europe and children whose parents objected to vaccination. By February 2010, there had been considerable spread to the general population.
Collapse
Affiliation(s)
- S Gee
- HSE-Health Protection Surveillance Centre, Dublin, Ireland
| | | | | | | |
Collapse
|
26
|
Martin J, O'Donnell J, Igoe D, O'Hora A, Thornton L, Murphy N, Cullen G, Fitzgerald M, Cotter S, McKeown P, O'Flanagan D. Enhanced surveillance of initial cases of pandemic H1N1 2009 influenza in Ireland, April-July 2009. ACTA ACUST UNITED AC 2009; 14. [PMID: 19814959 DOI: 10.2807/ese.14.38.19337-en] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
Abstract
From 28 April to 18 July 2009 there were 156 cases of pandemic H1N1 2009 influenza confirmed in Ireland. During this time, Ireland was in containment phase, and detailed case-based epidemiological information was gathered on all cases presenting in the community and acute health care setting. Active case finding was performed among contacts of cases. Eighty percent of cases were in people less than 35 years of age and 86% were imported. The most frequent symptoms were fever, sore throat, myalgia and dry cough. Nine people were hospitalized, no fatalities occurred.
Collapse
Affiliation(s)
- J Martin
- Health Protection Surveillance Centre, Dublin, Ireland.
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
27
|
Nicolay N, Cotter S. Clinical and epidemiological aspects of parvovirus B19 infections in Ireland, January 1996-June 2008. Euro Surveill 2009; 14:19249. [PMID: 19555594] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/28/2023] Open
Abstract
Parvovirus B19 infection may be mistakenly reported as measles or rubella if laboratory testing is not performed. As Europe is seeking to eliminate measles, an accurate diagnosis of fever/rash illnesses is needed. The main purpose of this study was to describe the epidemiological pattern of parvovirus B19, a common cause of rash, in Ireland between January 1996 and June 2008, using times series analysis of laboratory diagnostic data from the National Virus Reference Laboratory. Most diagnostic tests for presumptive parvovirus B19 infection were done in children under the age of five years and in women of child-bearing age (between 20-39 years-old). As a consequence, most of the acute diagnoses of B19 infection were made in these populations. The most commonly reported reasons for testing were: clinical presentation with rash, acute arthritis, influenza-like symptoms or pregnancy. The time series analysis identified seasonal trends in parvovirus B19 infection, with annual cycles peaking in late winter/spring and a six-year cycle for parvovirus B19 outbreaks in Ireland.
Collapse
Affiliation(s)
- N Nicolay
- Health Protection Surveillance Centre, Dublin, Ireland.
| | | |
Collapse
|
28
|
Abstract
Parvovirus B19 infection may be mistakenly reported as measles or rubella if laboratory testing is not performed. As Europe is seeking to eliminate measles, an accurate diagnosis of fever/rash illnesses is needed. The main purpose of this study was to describe the epidemiological pattern of parvovirus B19, a common cause of rash, in Ireland between January 1996 and June 2008, using times series analysis of laboratory diagnostic data from the National Virus Reference Laboratory. Most diagnostic tests for presumptive parvovirus B19 infection were done in children under the age of five years and in women of child-bearing age (between 20-39 years-old). As a consequence, most of the acute diagnoses of B19 infection were made in these populations. The most commonly reported reasons for testing were: clinical presentation with rash, acute arthritis, influenza-like symptoms or pregnancy. The time series analysis identified seasonal trends in parvovirus B19 infection, with annual cycles peaking in late winter/spring and a six-year cycle for parvovirus B19 outbreaks in Ireland.
Collapse
Affiliation(s)
- N Nicolay
- European Programme for Intervention Epidemiology Training (EPIET)
- Health Protection Surveillance Centre (HPSC), Dublin, Ireland
| | - S Cotter
- Health Protection Surveillance Centre (HPSC), Dublin, Ireland
| |
Collapse
|
29
|
Cotter S. National pneumococcal vaccination programmes for children in Europe, 2001-2007: update from Ireland. Euro Surveill 2009; 14:pii/19201; author reply pii/19200. [DOI: 10.2807/ese.14.18.19201-en] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Affiliation(s)
- S Cotter
- Health Protection Surveillance Centre, Dublin, Ireland
| |
Collapse
|
30
|
Barry J, Ward M, Cotter S, Macdiarmada J, Hannan M, Sweeney B, Grant KA, McKeown P. Botulism in injecting drug users, Dublin, Ireland, November-December 2008. Euro Surveill 2009; 14:19082. [PMID: 19161713] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/27/2023] Open
Abstract
In November and December 2008, six cases of suspect wound botulism were reported in heroin injecting drug users, all residents in Dublin, Ireland. Patients were aged between 23-42 years of age; four cases were male; one patient died shortly after admission. The patients presented to four different hospitals across the city. Botulism in injecting drug users in Ireland was last reported in 2002.
Collapse
Affiliation(s)
- J Barry
- Department of Public Health, Health Services Executive, Dublin, Ireland
| | | | | | | | | | | | | | | |
Collapse
|
31
|
Barry J, Ward M, Cotter S, MacDiarmada J, Hannan M, Sweeney B, Grant KA, McKeown P. Botulism in injecting drug users, Dublin, Ireland, November-December 2008. Euro Surveill 2009. [DOI: 10.2807/ese.14.01.19082-en] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
In November and December 2008, six cases of suspect wound botulism were reported in heroin injecting drug users, all residents in Dublin, Ireland. Patients were aged between 23-42 years of age; four cases were male; one patient died shortly after admission. The patients presented to four different hospitals across the city. Botulism in injecting drug users in Ireland was last reported in 2002.
Collapse
Affiliation(s)
- J Barry
- Department of Public Health and Primary Care, Trinity College, Dublin, Ireland
- Department of Public Health, Health Services Executive, Dublin, Ireland
| | - M Ward
- Department of Public Health, Health Services Executive, Dublin, Ireland
| | - S Cotter
- Health Protection Surveillance Centre, Dublin, Ireland
| | - J MacDiarmada
- Department of Public Health, Health Services Executive, Dublin, Ireland
| | - M Hannan
- Mater Misericordiae University, Hospital, Dublin, Ireland
| | - B Sweeney
- Addiction Service, Health Services Executive, Dublin, Ireland
- Mater Misericordiae University, Hospital, Dublin, Ireland
| | - K A Grant
- Foodborne Pathogen Reference Unit, Centre for Infections, London, United Kingdom
| | - P McKeown
- Health Protection Surveillance Centre, Dublin, Ireland
| |
Collapse
|
32
|
Mereckiene J, Cotter S, Nicoll A, Levy-Bruhl D, Ferro A, Tridente G, Zanoni G, Berra P, Salmaso S, O'Flanagan D, O Flanagan D. National seasonal influenza vaccination survey in Europe, 2008. ACTA ACUST UNITED AC 2008; 13. [PMID: 18947524 DOI: 10.2807/ese.13.43.19017-en] [Citation(s) in RCA: 75] [Impact Index Per Article: 4.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
Abstract
A cross-sectional survey was undertaken with the European Union (EU) Member States and Norway and Iceland to describe seasonal influenza immunisation in the 2006-7 season, in particular to identify country-specific recommendations for risk groups, obtain vaccine uptake information and allow comparison with global recommendations. A standardised questionnaire was completed electronically by each country's project gatekeeper. Of the 29 countries surveyed, 28 recommended seasonal influenza vaccination for older age groups (22 for those aged > 65 years), and in one country vaccine was recommended for all age groups. All countries recommended vaccinating patients with chronic pulmonary and cardiovascular diseases and most countries advised to immunise patients with haematologic or metabolic disorders (n=28), immunologic disorders (n=27) and renal disease (n=27), as well as residents of long-term care facilities (n=24). Most countries recommended vaccination for staff in hospitals (n=25), long-term care facilities (n=25) and outpatient clinics (n=23), and one-third had such recommendations for workers in essential (n=10), military (n=10) and veterinary services (n=10) and poultry industry (n=13). Eight countries recommended vaccine for pregnant women; and five advised to vaccinate children (with age limits ranging from 6 months to 5 years). Twenty countries measured influenza vaccine uptake among those aged > 65 years (range 1.8%-82.1%), seven reported uptake in healthcare workers (range 14%-48%) and seven assessed coverage in persons with underlying medical conditions (range 27.6%-75.2%). The data provided by this study can assist EU states to assess and compare their influenza vaccination programme performance with other countries. The information provides a comprehensive overview of policies and programmes and their outcomes and can be used to inform joint discussions on how the national policies in the EU might be standardised in the future to achieve optimal coverage. Annual surveys could be used to monitor changes in these national policies.
Collapse
Affiliation(s)
- J Mereckiene
- Health Protection Surveillance Centre, Dublin, Ireland.
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
33
|
Mereckiene J, Cotter S, Weber JT, Nicoll A, Lévy-Bruhl D, Ferro A, Tridente G, Zanoni G, Berra P, Salmaso S, O'Flanagan D, on behalf of the VENICE gatekeepers group C. Low coverage of seasonal influenza vaccination in the elderly in many European countries. Euro Surveill 2008; 13. [DOI: 10.2807/ese.13.41.19001-en] [Citation(s) in RCA: 24] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
In May 2003, the 56th World Health Assembly (WHA) recommended influenza vaccination for all people at high risk defined as the elderly and persons with underlying diseases [1]. The WHA countries, including all European Union (EU) Member States, also committed to the goal of attaining vaccination coverage of the elderly population of at least 50% by 2006 and 75% by 2010 and to having mechanisms for monitoring the uptake [1]. To date there has been no published survey on how successful European countries have been in implementing this WHA resolution.
Collapse
Affiliation(s)
- J Mereckiene
- Vaccine European New Integrated Collaboration Effort (VENICE) Project
- Health Protection Surveillance Centre, Dublin, Ireland
| | - S Cotter
- Health Protection Surveillance Centre, Dublin, Ireland
- Vaccine European New Integrated Collaboration Effort (VENICE) Project
| | - J T Weber
- Centers for Disease Control and Prevention (CDC), Atlanta, United States
- European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden
| | - A Nicoll
- European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden
| | - D Lévy-Bruhl
- Vaccine European New Integrated Collaboration Effort (VENICE) Project
- Institut de Veille Sanitare, Saint-Maurice, France
| | - A Ferro
- Vaccine European New Integrated Collaboration Effort (VENICE) Project
- Department of Prevention, Public Health Unit nr 17, Veneto Region, Italy
| | - G Tridente
- Vaccine European New Integrated Collaboration Effort (VENICE) Project
- The Green Channel Regional Reference Centre for Vaccination, Veneto, Italy
| | - G Zanoni
- Vaccine European New Integrated Collaboration Effort (VENICE) Project
- The Green Channel Regional Reference Centre for Vaccination, Veneto, Italy
| | - P Berra
- The Green Channel Regional Reference Centre for Vaccination, Veneto, Italy
- Vaccine European New Integrated Collaboration Effort (VENICE) Project
| | - S Salmaso
- Vaccine European New Integrated Collaboration Effort (VENICE) Project
- Istituto Superiore di Sanitá, Rome, Italy
| | - D O'Flanagan
- Health Protection Surveillance Centre, Dublin, Ireland
- Vaccine European New Integrated Collaboration Effort (VENICE) Project
| | | |
Collapse
|
34
|
Abstract
Following a national mumps outbreak that began in November 2004 and continued into 2005, the number of mumps notifications in Ireland waned in the latter half of 2006 and during 2007 (Figure 1). However, mumps notifications have started to increase again in 2008 (Figure 1). The number of mumps notifications annually between 1988 and 2008 and the number of confirmed mumps notifications by year from 2004 to 2008 are shown in Figure 2. In total, there were 420 mumps notifications in 2004, 1,079 in 2005, 427 in 2006, 150 in 2007 and to date there are 153 notifications in 2008 (Figure 2). In contrast, there were 40 mumps notifications in 2003 (Figure 2).
Collapse
Affiliation(s)
- S Gee
- Health Protection Surveillance Centre, Dublin, Ireland
| | | | | | | |
Collapse
|
35
|
Mereckiene J, O’Donnell J, Collins C, Cotter S, Igoe D, O’Flanagan D. Risk groups and uptake of influenza and pneumococcal vaccine in Ireland. Euro Surveill 2007; 12:E13-4. [DOI: 10.2807/esm.12.12.00756-en] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
In Ireland, influenza and pneumococcal vaccines are recommended for adults aged 65 years and over and for those with chronic illness or immunosuppression. Influenza vaccine is recommended for healthcare workers (HCWs) and residents of long stay care facilities. Influenza vaccine uptake is only available for those aged 65 years and over. We conducted a survey to estimate the size of risk groups between 18 and 64 years of age, influenza and pneumococcal vaccine uptake in this group, and to determine possible factors influencing vaccine uptake to improve targeted immunisation programmes. Among respondents aged 18-64 years, 136 of 1,218 (11%) belonged to a health risk group; uptake of influenza and pneumococcal vaccine in these risk groups was 28% (95% CI: 20.9-35.4) and 11% (95% CI: 6.7-17.2) respectively. Uptake among persons aged over 65 years was 69% (95% CI: 62.2-74.4) and 41% (95% CI: 35.0-47.9) for influenza and pneumococcal vaccine, respectively. Influenza vaccine uptake among HCWs was 20% (95% CI: 13.1-28.7). Half (47.6%) of influenza-vaccinated respondents reported that their family doctor had recommended it; 60% of non-vaccinated respondents, for whom influenza vaccine was indicated, saw themselves at low risk of influenza.
Collapse
Affiliation(s)
- J Mereckiene
- Health Protection Surveillance Centre (HPSC), Dublin, Ireland
- European Programme for Intervention Epidemiology Training (EPIET)
| | - J O’Donnell
- Health Protection Surveillance Centre (HPSC), Dublin, Ireland
| | - C Collins
- Irish College of General Practitioners (ICGP), Dublin, Ireland
| | - S Cotter
- Health Protection Surveillance Centre (HPSC), Dublin, Ireland
| | - D Igoe
- Health Protection Surveillance Centre (HPSC), Dublin, Ireland
| | - D O’Flanagan
- Health Protection Surveillance Centre (HPSC), Dublin, Ireland
| |
Collapse
|
36
|
Walsh T, Cotter S, Boland M, Greally T, O'Riordan R, Lyons D. Stroke unit care is superior to general rehabilitation unit care. Ir Med J 2006; 99:300-2. [PMID: 17274172] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/13/2023]
Abstract
Robust evidence exists for the efficacy of stroke units in improving stroke outcome. To date no Irish and little international data exist comparing stroke unit and general rehabilitation unit care. 207 patients admitted to a stroke unit (136--65.7%) and a general rehabilitation unit (71--34%) in the Mid-Western region from September 2000-August 2002 were included in the study. There was no difference in patient age, gender or admission criteria between the units. The stroke unit was associated with a shorter length of stay (mean 21 versus 33 days, p < 0.01) and a higher rate of home discharge (50% versus 38%, p < 0.01). Patient survival at discharge (86% versus 70.4%, p < 0.01), 3 months (84.5% versus. 69.5%, p < 0.01) and 6 months (81% versus. 66%, p < 0.01) post-admission was better among stroke unit patients.
Collapse
Affiliation(s)
- T Walsh
- Department of Medicine, Clinical Age Assessment Unit, Mid-Western Regional Hospital, Limerick
| | | | | | | | | | | |
Collapse
|
37
|
Scheiman M, Cotter S, Rouse M, Mitchell GL, Kulp M, Cooper J, Borsting E. Randomised clinical trial of the effectiveness of base-in prism reading glasses versus placebo reading glasses for symptomatic convergence insufficiency in children. Br J Ophthalmol 2005; 89:1318-23. [PMID: 16170124 PMCID: PMC1772876 DOI: 10.1136/bjo.2005.068197] [Citation(s) in RCA: 85] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
Abstract
PURPOSE To compare base-in prism reading glasses with placebo reading glasses for the treatment of symptomatic convergence insufficiency (CI) in children aged 9 to <18 years. METHODS In a randomised clinical trial, 72 children aged 9 to <18 years with symptomatic CI were assigned to either base-in prism glasses or placebo reading glasses. Symptom level, measured with a quantitative symptom questionnaire (CI Symptom Survey-V15), was the primary outcome measure. Near point of convergence and positive fusional vergence at near were secondary outcomes. RESULTS The mean (SD) CI Symptom Survey score decreased (that is, less symptomatic) in both groups (base-in prism glasses from 31.6 (10.4) to 16.5 (9.2); placebo glasses from 28.4 (8.8) to 17.5 (12.3)). The change in the CI Symptom Survey scores (p = 0.33), near point of convergence (p = 0.91), and positive fusional vergence (p = 0.59) were not significantly different between the two groups after 6 weeks of wearing glasses. CONCLUSIONS Base-in prism reading glasses were found to be no more effective in alleviating symptoms, improving the near point of convergence, or improving positive fusional vergence at near than placebo reading glasses for the treatment of children aged 9 to <18 years with symptomatic CI.
Collapse
Affiliation(s)
- M Scheiman
- Eye Institute, Pennsylvania College of Optometry, 1200 West Godfrey Ave, Philadelphia, PA 19141, USA.
| | | | | | | | | | | | | |
Collapse
|
38
|
Abstract
BACKGROUND Chronic heart failure (CHF) is a serious, common condition associated with frequent hospitalisation. Several different disease management interventions (clinical service organisation interventions) for patients with CHF have been proposed. OBJECTIVES To assess the effectiveness of disease management interventions for patients with CHF. SEARCH STRATEGY We searched: Cochrane CENTRAL Register of Controlled Trials (to June 2003); MEDLINE (January 1966 to July 2003); EMBASE (January 1980 to July 2003); CINAHL (January 1982 to July 2003); AMED (January 1985 to July 2003); Science Citation Index Expanded (searched January 1981 to March 2001); SIGLE (January 1980 to July 2003); DARE (July 2003); National Research Register (July 2003); NHS Economic Evaluations Database (March 2001); reference lists of articles and asked experts in the field. SELECTION CRITERIA Randomised controlled trials comparing disease management interventions specifically directed at patients with CHF to usual care. DATA COLLECTION AND ANALYSIS At least two reviewers independently extracted data information and assessed study quality. Study authors were contacted for further information where necessary. MAIN RESULTS Sixteen trials involving 1,627 people were included. We classified the interventions into three models: multidisciplinary interventions (a holistic approach bridging the gap between hospital admission and discharge home delivered by a team); case management interventions (intense monitoring of patients following discharge often involving telephone follow up and home visits); and clinic interventions (follow up in a CHF clinic). There was considerable overlap within these categories, however the components, intensity and duration of the interventions varied. Case management interventions tended to be associated with reduced all cause mortality but these findings were not statistically significant (odds ratio 0.86, 95% confidence interval 0.67 to 1.10, P = 0.23), although the evidence was stronger when analysis was limited to the better quality studies (odds ratio 0.68, 95% confidence interval 0.46 to 0.98, P = 0.04). There was weak evidence that case management interventions may be associated with a reduction in admissions for heart failure. It is unclear what the effective components of the case management interventions are. The single RCT of a multidisciplinary intervention showed reduced heart-failure related re-admissions in the short term. At present there is little available evidence to support clinic based interventions. AUTHORS' CONCLUSIONS The data from this review are insufficient for forming recommendations. Further research should include adequately powered, multi-centre studies. Future studies should also investigate the effect of interventions on patients' and carers' quality of life, their satisfaction with the interventions and cost effectiveness.
Collapse
Affiliation(s)
- S Taylor
- Centre for General Practice and Primary Care, St Bartholomew's and The Royal London School of Medicine and Dentistry, Mile End Road, London, UK, E1 4NS.
| | | | | | | | | | | | | | | |
Collapse
|
39
|
Abstract
BACKGROUND Rates of depression and anxiety in south Asian populations are lower than expected. It remains uncertain whether this reflects a real difference in prevalence or differences in case recognition and management. OBJECTIVE To examine whether concordance of culture or ethnicity between doctors and patients affects the prescribing rates for antidepressant and anxiolytic medications in general practice populations, taking into account demography, practice size and organization. METHOD A cross-sectional general practice study, using practice and demographic data from primary care trusts, doctors' place of qualification from the General Medical Council, combined with practice level prescribing data from the prescription pricing authority (PACT) for the period 2000-2002. Set in 139 practices in the east London primary care trusts (PCTs) of Tower Hamlets, Hackney and Newham, multiethnic areas with large populations of south Asian residents and doctors. The main outcome measure was the annual prescribing rates for each group of drugs, calculated as the mean of two years average daily quantities (ADQs) for each medication, divided by the practice population. RESULTS In east London the median prescribing rate (ADQs) for all antidepressants was 7.97 (inter-quartile range 4.91-10.76), for all anxiolytics and hypnotics 2.27 (interquartile range 1.11-3.96). There were significant differences in prescribing rates between practices with UK trained GPs and practices with south Asian trained GPs, with the highest rates of antidepressant prescribing in practices with UK trained GPs and low proportions of south Asian patients. No differences were found in anxiolytic and hypnotic prescribing rates between these practices. 57% of the variation in prescribing between practices could be explained by a model including the place of GP qualification, the proportion of registered women, older (>65) patients, and the list size per full time GP. CONCLUSIONS Compared with previous studies prescribing rates for antidepressants have almost doubled over five years, the greatest increase being for selective serotonin re-uptake inhibitors (SSRIs). There is a modest fall in prescribing rates for anxiolytics and hypnotics. Concordance between south Asian practice populations and doctors from similar south Asian cultures is not associated with an increase in antidepressant prescribing. Lower rates of prescribing in practices with south Asian trained doctors occur regardless of the ethnic composition of the practice population. Reasons for these differences are uncertain, but may include differences in explanatory models for presenting symptoms, and management strategies which rely less on a biomedical paradigm.
Collapse
Affiliation(s)
- S A Hull
- Centre for General Practice and Primary Care, Institute of Community Health Sciences, Queen Mary's School of Medicine and Dentistry, University of London, Medical Sciences Building, Mile End Road, London E1 4NS, UK.
| | | | | |
Collapse
|
40
|
Abstract
Since the beginning of 2004, 293 cases of measles have been reported in Ireland (incidence: 7.5/100 000 population). The increase in measles activity, particularly since May, has been widespread in the country
Collapse
Affiliation(s)
- S Gee
- National Disease Surveillance Centre, Dublin, Ireland
| | - M Carton
- National Disease Surveillance Centre, Dublin, Ireland
| | - S Cotter
- National Disease Surveillance Centre, Dublin, Ireland
| |
Collapse
|
41
|
Abstract
AIM The primary objective of the study was to evaluate the continuation rates of a relatively new long-acting method of contraception, Implanon. The secondary objective was to study discontinuations related to bleeding problems and their management. METHOD A retrospective review of records of women fitted with Implanon was undertaken during February 2000--January 2003. RESULTS Results from the secondary objective will be the subject of a separate communication. Of the 147 implants fitted, 132 records could be retrieved; of these, 97% of the women had pre-insertion counselling by the clinician. The most common indications for Implanon usage were choice of a long-acting method, unhappy experience with other contraceptive methods and suboptimal compliance with contraceptive pills and injectables. The median age of fitting was 25 years and 36% of the women were nulliparous. No problems were experienced with fitting or removal of implants. Twenty (15%) women were lost to follow-up. Twenty-two implants were removed by the end of the study period, with 12 (60%) removals attributed to prolonged heavy/light bleeding. There were no known pregnancies during the study. Given that 15% of the women could not be followed up or contacted, the assumed lifetimes of Implanon using the Kaplan-Meier method are 0.90 (95% confidence interval 0.82-0.95) at 12 months, 0.80 (0.67-0.88) at 24 months and 0.75 (0.58-0.85) at 35 months. The confirmed lifetimes are 0.84 (0.71-0.91) at 12 months, 0.63 (0.42-0.78) at 24 months and 0.53 (0.28-0.73) at 35 months. CONCLUSION Although not free of side-effects, Implanon can be a good choice for women who are properly informed and counselled and seek long-term 'forgettable' contraception.
Collapse
Affiliation(s)
- K Rai
- Walthamstow Forest Primary Care Trust and Queen Mary's and St Bart's Medical School, London
| | | | | |
Collapse
|
42
|
Abstract
A knowledge, attitude and practice study on vaccinations was undertaken among Irish parents and healthcare professionals between May and August 2001. Parents expressed fear of vaccine side effects, mistrust of health services, and felt poorly informed on the vaccination issues. According to group discussions, health professionals felt they lack time and user-friendly materials to properly inform the parents.
Collapse
Affiliation(s)
- S Cotter
- National Disease Surveillance Centre, Dublin, Ireland
| | | | | | | | | |
Collapse
|
43
|
Fei P, Wanner P, Cotter S. [A dynamic approach to the study of differences in life expectancy by sex in Switzerland from 1910-1911 to 1988-1993. An application of the decomposition methods developed by Pollard and d'Arriaga]. Schweiz Z Volkswirtsch Stat 2002; 133:741-54. [PMID: 12321328] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/26/2023]
|
44
|
Cotter S. Strom, BL ed. Pharmacoepidemiology. Third edition. Eur J Public Health 2002. [DOI: 10.1093/eurpub/12.2.155-a] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
45
|
Valli VE, Jacobs RM, Norris A, Couto CG, Morrison WB, McCaw D, Cotter S, Ogilvie G, Moore A. The histologic classification of 602 cases of feline lymphoproliferative disease using the National Cancer Institute working formulation. J Vet Diagn Invest 2000; 12:295-306. [PMID: 10907857 DOI: 10.1177/104063870001200401] [Citation(s) in RCA: 80] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
Abstract
Case information and histologic slides for 688 admissions of feline tissues from 12 veterinary institutions were assembled and reviewed to determine tissues obtained by biopsy or necropsy, age and sex of cat, tumor topography, feline leukemia viral antigen status, histologic frequency of mitoses, diagnosis, presence of necrosis, and presence and degree of sclerosis. Histologic sections were examined to place the lesions in one of the diagnostic categories of the National Cancer Institute working formulation (NCI WF) for lymphomas or lymphoid leukemia. Correlations between the various factors determined were tested using contingency tables and chi-square analysis to provide a statistical comparison between the levels of observations determined by case examination with the numbers expected from chance alone. Significant correlations (P < or = 0.05) were found between diagnosis and tumor topography, the frequency of mitoses, necrosis, sclerosis, and age, between mitoses and necrosis, topography, age, and feline leukemia viral infection status, between topography and necrosis and age, and between leukemia viral status and age. Significant correlations between diagnosis and tumor topography included a greater than expected number of cases of acute and chronic lymphoid leukemia and multicentric distribution of tumor. Small cell lymphomas were more frequent than expected in enteric and cutaneous areas and less frequent than expected in mediastinal, renal, and multicentric areas. In contrast, the high-grade small noncleaved type of lymphomas was found significantly more frequently than expected in the mediastinum and less frequently than expected in enteric tissues. In comparing diagnosis and frequency of mitoses, the lymphomas classified as low grade by the NCI WF were significantly more frequent than expected in the lower categories (0-2/100x) of mitoses, and those classified as high-grade lymphomas were more frequent than expected in the higher categories (4-8/1OOx) of mitoses. In comparing diagnosis and sclerosis, diffuse sclerosis was more frequent than expected for the intermediate grade lymphomas of mixed cell type and for the high-grade lymphomas of the immunoblastic polymorphous type. In comparing diagnosis and locally extensive necrosis, this feature was more frequently observed than expected for cases of intermediate grade lymphoma of the small-cleaved cell category and for the high-grade lymphoma of the immunoblastic cell type. In comparing mitoses and necrosis, the lower grade lymphomas were, in general, characterized by a lower frequency of mitoses and a lower incidence of necrosis then would be expected from chance alone. In contrast, the higher grade lymphomas were characterized by more frequent mitoses and a higher incidence of necrosis. In tests comparing mitoses and tumor topography, lymphomas of the alimentary tract were more frequently observed than expected in the category with the lowest level of mitoses (0-1/100x), whereas lymphomas of the mediastinum and kidney were more frequently observed than expected in the categories with a higher level (4-20/ 100x) of mitoses.
Collapse
Affiliation(s)
- V E Valli
- College of Veterinary Medicine, University of Illinois, Urbana 61802, USA
| | | | | | | | | | | | | | | | | |
Collapse
|
46
|
Aprelikova ON, Fang BS, Meissner EG, Cotter S, Campbell M, Kuthiala A, Bessho M, Jensen RA, Liu ET. BRCA1-associated growth arrest is RB-dependent. Proc Natl Acad Sci U S A 1999; 96:11866-71. [PMID: 10518542 PMCID: PMC18378 DOI: 10.1073/pnas.96.21.11866] [Citation(s) in RCA: 114] [Impact Index Per Article: 4.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022] Open
Abstract
BRCA1 is a susceptibility gene for breast and ovarian cancer with growth-inhibitory activity for which the mechanism of action remains unclear. When introduced into cells, BRCA1 inhibits growth of some but not all cell lines. In an attempt to uncover the mechanism of growth suppression by BRCA1, we examined a panel of cell lines for their ability to reduce colony outgrowth in response to BRCA1 overexpression. Of all variables tested, only those cells with wild-type pRb were sensitive to BRCA1-induced growth suppression. In cells with an intact rb gene, inactivation of pRb by HPV E7 abrogates the growth arrest imposed by BRCA1. In accordance with these observations, we found that BRCA1 could not suppress BrdUrd uptake in primary fibroblasts from rb-/- mice and exhibited an intermediate ability to inhibit DNA synthesis in rb+/- as compared with rb+/+ cells. We further found that the BRCA1 protein complexes with the hypophosphorylated form of pRb. This binding is localized to amino acids 304-394 of BRCA1 protein and requires the ABC domain of pRb. In-frame deletion of BRCA1 fragment involved in interaction with pRb completely abolished the growth-suppressive property of BRCA1. Although it has been reported that BRCA1 interacts with p53, we find the p53 status did not affect the ability of BRCA1 to suppress colony formation. Our data suggest that the growth suppressor function of BRCA1 depends, at least in part, on Rb.
Collapse
Affiliation(s)
- O N Aprelikova
- Section of Molecular Signaling and Oncogenesis, Division of Clinical Sciences, National Cancer Institute, Bethesda, MD 20892, USA
| | | | | | | | | | | | | | | | | |
Collapse
|
47
|
Wanner P, Peng F, Cotter S. [Mortality by age and cause of death in Switzerland: an analysis of cantonal disparities during the period 1978/83-1988/93]. Eur J Popul 1997; 13:381-99. [PMID: 12348441 DOI: 10.1023/a:1005993113820] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
|
48
|
Diserens D, Giger U, Bull R, Cotter S, Meyers K, Smith J, Wardrop J. The lecture vs. the journal article. Acad Med 1994; 69:976-977. [PMID: 7999191 DOI: 10.1097/00001888-199412000-00013] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/22/2023]
|
49
|
Abstract
OBJECTIVE To investigate systematically participation in audit of NHS hospital pharmacists in the United Kingdom. DESIGN Questionnaire census survey. SETTING All NHS hospital pharmacies in the UK providing clinical pharmacy services. SUBJECTS 462 hospital pharmacies. MAIN MEASURES Extent and nature of participation in medical, clinical, and pharmacy audits according to hospital management and teaching status, educational level and specialisation of pharmacists, and perceived availability of resources. RESULTS 416 questionnaires were returned (response rate 90%). Pharmacists contributed to medical audit in 50% (204/410) of hospitals, pharmacy audit in 27% (108/404), and clinical audit in only 7% (29/404). Many pharmacies (59% (235/399)) were involved in one or more types of audit but few (4%, (15/399)) in all three. Participation increased in medical and pharmacy audits with trust status (medical audit: 57% (65/115) trust hospital v 47% (132/281) non-trust hospital; pharmacy audit: 34% (39/114) v 24% (65/276)) and teaching status (medical audit: 58% (60/104) teaching hospital v 47% (130/279) non-teaching hospital; pharmacy audit 30% (31/104) v 25% (68/273)) and similarly for highly qualified pharmacists (MPhil or PhD, MSc, diplomas) (medical audit: 54% (163/302) with these qualifications v 38% (39/103) without; pharmacy audit: 32% (95/298) v 13% (13/102)) and specialists pharmacists (medical audit: 61% (112/184) specialist v 41% (90/221) non-specialist; pharmacy audit: 37% (67/182) v 19% (41/218)). Pharmacies contributing to medical audit commonly provided financial information on drug use (86% 169/197). Pharmacy audits often concentrated on audit of clinical pharmacy services. CONCLUSION Pharmacists are beginning to participate in the critical evaluation of health care, mainly in medical audit.
Collapse
Affiliation(s)
- S Cotter
- Department of Public Health and Policy, London School of Hygiene and Tropical Medicine
| | | | | |
Collapse
|
50
|
|